Breast Carcinoma
Oncology·MeSH: Breast Neoplasms
6 drugs in development·4 companies·16 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| cyclophosphamide | NEXUS BIOPHARMA INC (NEXS) |
Phase 3(1)
| Drug | Company |
|---|---|
| OP-1250 | Olema Pharmaceuticals, Inc. (OLMA) |
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| Berzosertib | Merus N.V. (MRUS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Breast Carcinoma?
BioSniper tracks 6 drugs in development for Breast Carcinoma across 4 companies.
How many clinical trials target Breast Carcinoma?
There are 16 clinical trials targeting Breast Carcinoma tracked by BioSniper.
Deep-dive into Breast Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis